# Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/best-practices-in-developing-proprietary-names-for-human-prescription-drug-products-guidance-for-industry-guidance-for-industry/884d34d7-a96d-446a-8c81-afb4c4e499ac

> FDA guidance document: Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry:  Guidance for Industry. Issue date: December 08, 2020. Get complete insights and analysis.

---

## Details

- Title: Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-12-08
- Last Changed: 2020-12-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0622">FDA-2014-D-0622</a>

## Related Documents

- [Referencing Approved Drug Products in ANDA Submissions Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/referencing-approved-drug-products-in-anda-submissions-guidance-for-industry/a3f26b8f-0c5a-443b-b665-6fef99ae7de4)
- [Contents of a Complete Submission for the Evaluation of Proprietary Names](https://www.globalkeysolutions.net/guidances/guidance-document/contents-of-a-complete-submission-for-the-evaluation-of-proprietary-names/8bbe789c-b7fd-4a76-9e78-6ea3344719df)
- [Homeopathic Drug Products Guidance for FDA Staff and Industry](https://www.globalkeysolutions.net/guidances/guidance-document/homeopathic-drug-products-guidance-for-fda-staff-and-industry/f8c7cdc9-599a-4ab0-9f93-eeb2b899427c)